Proctitis and ulcerative colitis are not the same thing, but they’re closely related. Ulcerative proctitis is actually a subtype of ulcerative colitis, one where inflammation is confined to the rectum rather than spreading further up the colon. Think of ulcerative colitis as the umbrella category and proctitis as the mildest form under that umbrella. About 46% of all ulcerative colitis patients have disease limited to the rectum or the nearby sigmoid colon.
That said, not all proctitis is ulcerative colitis. Proctitis simply means inflammation of the rectum, and it can be caused by infections, sexually transmitted infections, radiation therapy, or inflammatory bowel disease. When your doctor says “ulcerative proctitis,” they specifically mean the form linked to ulcerative colitis.
How Ulcerative Colitis Is Classified by Location
Ulcerative colitis is categorized by how far inflammation extends along the colon. The four main types are:
- Ulcerative proctitis: inflammation limited to the rectum, typically the last six inches or less of the digestive tract
- Proctosigmoiditis: inflammation extending into the sigmoid colon, the S-shaped section just above the rectum
- Left-sided colitis: inflammation reaching up to about 60 cm from the anus, covering the left side of the colon
- Pancolitis: inflammation affecting most or all of the colon
Doctors determine which type you have during a colonoscopy or flexible sigmoidoscopy, where a thin, lighted tube lets them see the lining of your colon and take small tissue samples. This distinction matters because the extent of disease shapes your treatment plan, your cancer risk, and what you can expect long term. It’s so common for patients to blur these categories that gastroenterologists regularly see new patients who say they have “ulcerative colitis” when they actually have proctitis or proctosigmoiditis.
Symptoms of Ulcerative Proctitis
Because the inflammation sits right at the end of the digestive tract, ulcerative proctitis tends to produce a distinct cluster of symptoms centered around the rectum. The hallmark is tenesmus, a persistent feeling that you need to have a bowel movement even when your bowel is empty. This can be one of the most frustrating symptoms because it doesn’t go away after using the bathroom.
Other common symptoms include rectal bleeding (often bright red blood on toilet paper or mixed with stool), passing mucus or pus, cramping pain in the rectum or lower left abdomen, and sudden urgency. Some people experience constipation rather than diarrhea, which surprises patients who associate colitis with loose stools. In more extensive forms of ulcerative colitis, diarrhea tends to be more prominent, and symptoms like weight loss, fatigue, and fever become more likely as more of the colon is involved.
Despite being the “mildest” classification, ulcerative proctitis can significantly reduce quality of life. Urgency, incontinence, and constant rectal discomfort make daily activities stressful, and many patients describe the condition as genuinely disabling even though the area of inflammation is small.
Can Proctitis Spread Into Full Colitis?
Yes, and this is one of the most important things to understand about ulcerative proctitis. It doesn’t always stay put. Studies report that 10 to 20% of proctitis patients see their disease extend further up the colon within five years, and that number climbs to 28 to 54% at ten years. One study tracking 77 patients found that about 42% had inflammation spread beyond the rectum to the rectosigmoid junction within an average of five years.
This is a key reason doctors treat ulcerative proctitis seriously rather than adopting a wait-and-see approach. Effective, timely management aims not only to control symptoms but also to delay or prevent the inflammation from creeping further up the colon. Once disease becomes more extensive, treatment becomes more complex and the long-term risks increase.
How Treatment Differs
Because the inflammation in ulcerative proctitis is localized to a small, accessible area, treatment often starts with topical medications delivered directly to the rectum, typically as suppositories or enemas containing an anti-inflammatory compound. This approach gets medication right where it’s needed with fewer side effects than oral medications. Many patients with proctitis can achieve remission with topical therapy alone, which isn’t realistic for someone with inflammation spanning most of the colon.
More extensive ulcerative colitis usually requires oral anti-inflammatory medications, immune-suppressing drugs, or biologic therapies that work throughout the body. The treatment escalation is generally proportional to how much colon is involved and how severe the symptoms are.
That said, proctitis isn’t always easy to control. In one long-term study from a major referral center, about 31% of ulcerative proctitis patients were refractory to standard therapy and needed more aggressive treatment. For those patients, biologic medications showed mixed results: roughly half responded to one class of biologic, while about 67% responded to another. Patients in this refractory group often waited years (a median of over six years) before starting biologic therapy. One frustrating reality is that patients with proctitis alone are typically excluded from the large clinical trials that test newer medications, which means treatment options for stubborn cases are less well studied.
Cancer Risk Is Different
One area where the distinction between proctitis and extensive colitis matters enormously is colorectal cancer risk. The risk is proportional to how much of the colon is inflamed. Patients with pancolitis face roughly a 20-fold increased risk of colorectal cancer compared to the general population, and those with left-sided colitis have about a fourfold increase. One study found a 5.4% cancer incidence rate specifically among pancolitis patients over time.
Ulcerative proctitis, by contrast, is not associated with an increased risk of colorectal cancer according to the Crohn’s & Colitis Foundation. This is directly because of the limited area of inflammation. However, if your proctitis extends over the years into more of the colon, your risk profile changes with it, which is another reason regular follow-up matters even when symptoms feel manageable.
How Doctors Confirm the Diagnosis
If you’re experiencing rectal bleeding, urgency, or tenesmus, your doctor will typically start with stool tests to rule out bacterial infections and may test for sexually transmitted infections, since STIs are a common non-IBD cause of rectal inflammation. The definitive step is a scope exam. A flexible sigmoidoscopy examines just the rectum and lower colon and is often sufficient to diagnose proctitis, but a full colonoscopy may be performed to see the entire colon and confirm that inflammation hasn’t spread further than expected. During either procedure, your doctor will take small tissue biopsies to examine under a microscope, which helps confirm ulcerative colitis as the cause and rule out other conditions like Crohn’s disease.
The scope exam is what ultimately determines whether you have proctitis, proctosigmoiditis, left-sided colitis, or pancolitis. If you’ve been told you have ulcerative colitis but aren’t sure which subtype, asking your gastroenterologist about the extent of your disease is worth the conversation. It changes what treatment makes sense, what your cancer screening schedule looks like, and what to watch for going forward.